Return to study ST001846 main page
MB Sample ID: SA171686
| Local Sample ID: | tCFZ3_POS |
| Subject ID: | SU001923 |
| Subject Type: | Mammal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
| Genotype Strain: | Balb/c |
| Age Or Age Range: | 8-12 weeks old |
| Weight Or Weight Range: | 20-25 g |
| Gender: | Female |
| Animal Feed: | ad libitum |
| Animal Water: | ad libitum |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR001935 |
| Treatment Summary: | Injections with CFZ (16 mg/kg, iv), BTZ (1 mg/kg, iv), CFZ+atRA (CFZ: 16 mg/kg iv, atRA: 1 mg/kg iv) or Captisol (Vehicle, iv) |
| Treatment Compound: | Bortezomib (PS-34, Selleck Chemicals, S1013); Carfilzomib (PR-171, Selleck Chemicals, S2853); all-trans-Retinoic-Acid (Sigma-Aldrich, R2625); Captisol (Ligand Pharmaceuticals |
| Treatment Route: | i.v |
| Treatment Dose: | As described in treatment summary |
| Treatment Vehicle: | Captisol |
| Animal Anesthesia: | Induction with Ketamine 80 mg/kg intramuscular and maintained with Isoflurane 0.5% |
| Animal Endp Euthanasia: | 1h |
| Animal Endp Tissue Coll List: | 1h |
